DEI CAS, Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 9.333
AS - Asia 8.367
EU - Europa 5.433
SA - Sud America 1.243
AF - Africa 388
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 24.782
Nazione #
US - Stati Uniti d'America 9.075
SG - Singapore 3.324
CN - Cina 2.123
VN - Vietnam 1.303
IT - Italia 1.114
BR - Brasile 980
IE - Irlanda 948
HK - Hong Kong 694
DE - Germania 641
FI - Finlandia 581
SE - Svezia 534
UA - Ucraina 396
TR - Turchia 296
NL - Olanda 288
ZA - Sudafrica 275
FR - Francia 273
CA - Canada 168
GB - Regno Unito 127
RO - Romania 123
RU - Federazione Russa 115
IN - India 100
AR - Argentina 97
IQ - Iraq 74
BD - Bangladesh 71
AT - Austria 57
JP - Giappone 52
EC - Ecuador 49
MX - Messico 49
ES - Italia 45
ID - Indonesia 45
BE - Belgio 43
PL - Polonia 39
PH - Filippine 32
MA - Marocco 30
PK - Pakistan 30
UZ - Uzbekistan 29
CZ - Repubblica Ceca 28
CO - Colombia 27
PY - Paraguay 25
VE - Venezuela 21
AE - Emirati Arabi Uniti 20
KR - Corea 20
SA - Arabia Saudita 20
CL - Cile 18
LT - Lituania 17
MY - Malesia 16
TH - Thailandia 16
CI - Costa d'Avorio 15
JO - Giordania 15
TN - Tunisia 14
AZ - Azerbaigian 12
EG - Egitto 12
HR - Croazia 12
KE - Kenya 12
LB - Libano 11
PE - Perù 10
UY - Uruguay 10
DO - Repubblica Dominicana 9
GE - Georgia 9
KG - Kirghizistan 9
IR - Iran 8
PT - Portogallo 8
AU - Australia 7
IL - Israele 7
PA - Panama 7
AL - Albania 6
EU - Europa 6
BG - Bulgaria 5
RS - Serbia 5
SV - El Salvador 5
TT - Trinidad e Tobago 5
BO - Bolivia 4
CR - Costa Rica 4
DK - Danimarca 4
ET - Etiopia 4
HU - Ungheria 4
NG - Nigeria 4
NP - Nepal 4
OM - Oman 4
TW - Taiwan 4
AO - Angola 3
CY - Cipro 3
DZ - Algeria 3
JM - Giamaica 3
LV - Lettonia 3
NI - Nicaragua 3
PS - Palestinian Territory 3
SN - Senegal 3
BW - Botswana 2
BY - Bielorussia 2
CG - Congo 2
CH - Svizzera 2
GR - Grecia 2
GY - Guiana 2
HN - Honduras 2
IM - Isola di Man 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LY - Libia 2
MU - Mauritius 2
Totale 24.751
Città #
Singapore 1.641
Ashburn 967
Dublin 943
Chandler 932
San Jose 844
Jacksonville 702
Dallas 661
Hong Kong 628
Beijing 540
Santa Clara 468
Ho Chi Minh City 398
Parma 356
Boardman 344
Dearborn 337
Ann Arbor 311
Hanoi 310
Nanjing 272
Johannesburg 251
Izmir 240
Lauterbourg 207
Princeton 206
Los Angeles 158
San Mateo 145
New York 137
Munich 124
Shanghai 117
Focsani 111
Wilmington 103
Toronto 96
Helsinki 88
Hefei 81
Des Moines 78
São Paulo 78
Columbus 73
Shenyang 73
Buffalo 69
Milan 68
Council Bluffs 66
Moscow 64
Nanchang 64
Frankfurt am Main 61
Da Nang 55
Kunming 54
Haiphong 52
Seattle 50
Hebei 45
Guangzhou 44
Tianjin 43
Vienna 43
Bologna 42
Jinan 42
The Dalles 41
Rome 40
Tokyo 38
Changsha 37
Grafing 36
Jiaxing 34
London 34
Chicago 33
Nuremberg 33
Orem 32
Montreal 31
Amsterdam 30
Baghdad 30
Houston 30
Turku 30
Bremen 29
Rio de Janeiro 29
Brussels 28
Biên Hòa 27
Norwalk 26
Warsaw 26
Brooklyn 25
Jakarta 24
Woodbridge 24
Chennai 23
Phoenix 23
Tashkent 23
Naples 21
Curitiba 20
Denver 20
Quito 20
Stockholm 20
Boston 19
Atlanta 17
Zhengzhou 17
Brasília 16
Dong Ket 16
Abidjan 15
Amman 15
Düsseldorf 15
Hải Dương 15
Belo Horizonte 14
Brno 14
Fremont 14
Istanbul 14
Piacenza 14
Redondo Beach 14
Salvador 14
Campinas 13
Totale 15.055
Nome #
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes 11 Medical and Health Sciences 1103 Clinical Sciences 260
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the area of blood glucose and insulin concentrations 257
Effect of coffee and cocoa-based confectionery containing coffee on markers of cardiometabolic health: results from the pocket-4-life project 233
Chronic consumption of a bergamot-based beverage does not affect glucose, lipid and inflammatory biomarkers of cardiometabolic risk in healthy subjects: a randomised controlled intervention study 232
[AMD Annals: a model of continuous monitoring and improvement of the quality of diabetes care]. 218
Claimed effects, outcome variables and methods of measurement for health claims proposed under Regulation (EC) 1924/2006 in the framework of bone health 214
Absorption, Pharmacokinetics, and Urinary Excretion of Pyridines After Consumption of Coffee and Cocoa-Based Products Containing Coffee in a Repeated Dose, Crossover Human Intervention Study 213
Sodium-glucose cotransporter 2 inhibitors antagonize lipotoxicity in human myeloid angiogenic cells and ADP-dependent activation in human platelets: Potential relevance to prevention of cardiovascular events 213
Claimed effects, outcome variables and methods of measurement for health claims proposed under European community regulation 1924/2006 in the framework of maintenance of skin function 206
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health. 204
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under European Community Regulation 1924/2006 in the area of appetite ratings and weight management 204
Metabolomic Changes after Coffee Consumption: New Paths on the Block 204
Pasta Structure Affects Mastication, Bolus Properties, and Postprandial Glucose and Insulin Metabolism in Healthy Adults 197
Claimed effects, outcome variables and methods of measurement for health claims on foods proposed under Regulation (EC) 1924/2006 in the area of oral health 196
Bioavailability of Bergamot (Citrus bergamia) Flavanones and Biological Activity of Their Circulating Metabolites in Human Pro-Angiogenic Cells 191
Correction: Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects(PLoS ONE (2018)12:8(e0182559) DOI: 10.1371/journal.pone.0182559) 184
Claimed effects, outcome variables and methods of measurement for health claims on foods related to the gastrointestinal tract proposed under regulation (EC) 1924/2006 184
Effects of TiO2 and Co3O4 Nanoparticles on Circulating Angiogenic Cells 173
Claimed Effects, Outcome Variables and Methods of Measurement for Health Claims on Foods Related to Vision Proposed Under Regulation (EC) 1924/2006 171
Abitudini alimentari e quadro metabolico in un campione di body builders 169
Caso di acute generalised exanthematous pustolosis (AGEP) associato a grave ipotiroidismo. 168
ADMA, oxidative stress and endothelial dysfunction: a vicious atherogenic loop? 167
Effect of different patterns of consumption of coffee and a cocoa-based product containing coffee on the nutrikinetics and urinary excretion of phenolic compounds 163
Effect of coffee and cocoa-based confectionery containing coffee on markers of dna damage and lipid peroxidation products: Results from a human intervention study 162
PKCε is a negative regulator of PVAT-derived vessel formation 161
Autosomministrazione di steroidi anabolizzanti androgeni (AAS) in body-builders: uso di supplementi nutrizionali. 161
Effects of the GABAergic agonist baclofen on endurance performance in recreational athletes: a pilot study 161
A performance score of the quality of inpatient diabetes care is a marker of clinical outcomes and suggests a cause-effect relationship between hypoglycaemia and the risk of in-hospital mortality 160
Evidence for a Modulatory Effect of a 12‐Week Pomegranate Juice Intervention on the Transcriptional Response in Inflammatory Bowel Disease Patients Reducing Fecal Calprotectin Levels: Findings From a Proof‐of‐Principle Study 159
Autosomministrazione di steroidi anabolizzanti androgeni (AAS) in body-builders: abitudini alimentari 159
Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells 157
Autosomministrazione dei steroidi anabolizzanti androgeni (AAS) in body-builders: uso di supplementi nutrizionali 150
Controllo dell'omeostasi energetica e del peso corporeo nell'obesità 150
Effects of raloxifene and continuous combined hormone therapy on haemostasis variables: a multicenter, randomized, double-blind study 146
Dysfunctional eating in type 2 diabetes mellitus: A multicenter Italian study of socio-demographic and clinical associations 146
Performance and antrhropometric characteristics of Elite Rugby Players. 146
How (poly)phenols can shape a healthier life? A nutri-omics investigation on their cardiometabolic health effects 143
N-3 PUFA increase bioavailability and function of endothelial progenitor cells. 142
Stage of change and motivation to healthy diet and habitual physical activity in type 2 diabetes. 142
Empagliflozin does not reverse lipotoxicity-induced impairment in human myeloid angiogenic cell bioenergetics 142
Activation of G protein-coupled receptors by ketone bodies: Clinical implication of the ketogenic diet in metabolic disorders 141
Abitudini alimentari e quadro metabolico in un campione di body builders facente uso di integratori alimentari: dati preliminari 141
Transcriptomic analysis of human polarized macrophages: More than one role of alternative activation? 141
Telomere length is independently associated with subclinical atherosclerosis in subjects with type 2 diabetes: a cross-sectional study 141
Claimed effects, outcome variables and methods of measurement for health claims proposed under regulation (EC) 1924/2006 and related to cognitive function in adults 139
Nutri-omics: how omics investigation can help designing personalized nutrition research 138
Celiachia: una malattia sempre attuale 137
Celiachia nell'adulto: rassegna della letteratura e recenti strategie terapeutiche 136
Identification of an early transcriptomic signature of insulin resistance and related diseases in lymphomonocytes of healthy subjects 136
Stearic acid at physiologic concentrations induces in vitro lipotoxicity in circulating angiogenic cells 135
Dislipidemia diabetica e spessore medio-intimale, ruolo del trasporto inverso del colesterolo. 135
Caratterizzazione fenotipica e funzionale di cellule progenitrici endoteliali coltivate ex vivo: effetto degli acidi grassi omega 3 e dei glitazoni. 132
Vildagliptin, but not glibenclamide, increases circulating endothelial progenitor cell number: A 12-month randomized controlled trial in patients with type 2 diabetes 132
Assenza di effetti del diabete mellito sull’efficacia e tollerabilità della terapia beta bloccante nei pazienti con insufficienza cardiaca cronica. 131
Diabetes and chronic heart failure: from diabetic cardiomyopathy to therapeutic approach. 131
Cardiovascular prevention in women: a narrative review from the Italian Society of Cardiology working groups on 'Cardiovascular Prevention, Hypertension and peripheral circulation' and on 'Women Disease' 131
Hyperglycemia in the diabetic range, but not previous diagnosis of diabetes mellitus, is an independent indicator of poor outcome in patients hospitalized for severe COVID-19 129
Podocyte specific induced overexpression of angiopoietin-2 causesproteinuria and apoptosis of glomerular endothelia 128
Caratterizzazione fenotipica e funzionale di cellule progenitrici endoteliali coltivate ex vivo, effetti del PPARγ agonista pioglitazone: risultati preliminari. 126
SARS-CoV-2 Spike protein is not pro-inflammatory in human primary macrophages: endotoxin contamination and lack of protein glycosylation as possible confounders 126
GADA Titer-Related Risk for Organ-Specific Autoimmunity in LADA Subjects Subdivided according to Gender (NIRAD Study 6) 125
Reduced circulating endothelial progenitor cell number in healthy young adult hyperinsulinemic men 124
Terapia farmacologica dell’ obesità 124
Neue Erkenntnisse zur gefährlichen Verbindung von Diabetes und Herzversagen 121
Claimed effects, outcome variables and methods of measurement for health claims proposed under European Community Regulation 1924/2006 in the framework of protection against oxidative damage and cardiovascular health 119
Insulino-resistenza e rischio cardiovascolare 119
Ridotto numero di Cellule Progenitrici Endoteliali in soggetti giovani sani insulino resistenti di genere maschile. 117
Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial 116
Phenotypic and functional characterization of endothelial progenitor cells and effects of n3-PUFA. 116
Six-year prognosis of diabetic patients with coronary artery disease. 116
Uso di supplementi nutrizionali ed abitudini alimentari in 20 body builders seguiti per 24 mesi. 115
Ridotto numero di Cellule Progenitrici Endoteliali in soggetti giovani sani insulino-resistenti di genere maschile 113
Compromissione precoce dell’asse entero-insulare in corso di diabete mellito Tipo 2 (non insulino dipendente) 112
Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome 112
Uso di supplementi vitaminici in un gruppo di 22 body builders studiati per un periodo di 24 mesi 111
Heart Failure Study Group of the Italian Society of Cardiology. Cardiovascular and noncardiovascular comorbidities in patients with chronic heart failure. 111
Whole-genome transcription profile in lympho-monocytes of healthy volunteers reveals over-expression of oxidative phosphorylation and cell cycle genes in presence of increased IM 110
Energy homeostasis and body weight in obesity: new physiopathological and therapeutic considerations 110
The role of physical activity in individuals with cardiovascular risk factors: An opinion paper from Italian Society of Cardiology-Emilia Romagna-Marche and SIC-Sport 109
Problemi nutrizionali nella terza età. 109
Similar effectiveness of dapagliflozin and GLP-1 receptor agonists concerning combined endpoints in routine clinical practice: A multicentre retrospective study 108
Definizione del rischio cardiovascolare globale in pazienti diabetici tipo 2 mediante l’utilizzo delle carte italiane del RISKARD: risultati preliminari. 108
Effectiveness of the flash glucose monitoring system in preventing severe hypoglycemic episodes and in improving glucose metrics and quality of life in subjects with type 1 diabetes at high risk of acute diabetes complications 107
Effect of nutrient ingestion on glucagon-like peptide 1 (7-36 amide) secretion in human type 1 and type 2 diabetes 107
Epidemiologia della Sindrome Metabolica. In: Insulino-resistenza e sindrome metabolica 107
Valutazione del tono vagale tramite determinazione di polipeptide pancreatico nella obesità morbigena. 107
Definizione del rischio cardiovascolare globale in pazienti diabetici tipo 2 mediante l’utilizzo delle carte italiani del RISKARD. 106
Prevention and management of chronic heart failure in patients at risk 106
Efficacy and tolerability of long-term beta-blocker therapy in the patients with heart failure and concomitant diabetes mellitus 106
Characterization of skeletal parameters in a cohort of North Italian rugby players 105
Effects of a new nutraceutical formulation (Berberine, red yeast rice and chitosan) on non-HDL cholesterol levels in individuals with dyslipidemia: Results from a randomized, double blind, placebo-controlled study 105
Side effects of Anabolic Androgenic Steroids abuse 104
Fisiopatologia della cachessia nella insufficienza cardiaca: ruolo del sistema neuroendocrino 104
High GADA titer increases the risk of insulin requirement in LADA patients: A 7-year follow-up (NIRAD study 7) 104
Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion. 103
Ridotti livelli circolanti di Glucagon-like peptide 1 (GLP-1) 7-36 amide nell’ obesita’: difetto di secrezione o aumentata degradazione del peptide? 103
i problemi nutrizionali della terza età alla fine del secondo millennio 103
Do Changes of Urinary Albumin Excretion Predict Cardiovascular Events? A Meta-regression Analysis of 32 Randomized Trials. 103
The favourable effect of weight loss on the cardiac sympatho-vagal drive is the main determinant of the left-ventricular hypertrophy regression in the obese patients. 103
Cigarette smoking and high LDL-cholesterol concentrations are associated with two different but additive proinflammatory gene expression signatures in circulating mononuclear cells. 101
Totale 14.303
Categoria #
all - tutte 85.027
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.027


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021237 0 0 0 0 0 0 0 0 0 19 163 55
2021/2022986 31 34 26 30 28 50 135 146 56 74 21 355
2022/20233.301 375 222 173 252 280 416 14 214 1.168 14 137 36
2023/20241.267 78 126 47 36 119 263 85 74 44 47 125 223
2024/20254.517 64 264 312 242 455 405 168 265 612 444 375 911
2025/20269.661 761 1.061 1.173 811 1.432 651 1.327 390 1.381 674 0 0
Totale 24.975